Cargando…

Risk factors for COVID-19 mortality in hospitalized patients in Bolivia

OBJECTIVES: This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. METHODS: This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Limachi-Choque, Jhonny, Guitian, Javier, Leyns, Christine, Guzman-Rivero, Miguel, Eid, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643226/
https://www.ncbi.nlm.nih.gov/pubmed/38020182
http://dx.doi.org/10.1016/j.ijregi.2023.10.002
_version_ 1785134309958483968
author Limachi-Choque, Jhonny
Guitian, Javier
Leyns, Christine
Guzman-Rivero, Miguel
Eid, Daniel
author_facet Limachi-Choque, Jhonny
Guitian, Javier
Leyns, Christine
Guzman-Rivero, Miguel
Eid, Daniel
author_sort Limachi-Choque, Jhonny
collection PubMed
description OBJECTIVES: This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. METHODS: This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infection in a Bolivian hospital between April 6, 2020, and August 18, 2022. RESULTS: The results provide evidence of association between male sex (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.06-2.6), older age, 51-61 years-old (OR = 5.2, 95% CI 2.2-12.6), 62-70 years-old (OR = 8.7, 95% CI 3.7-20.5), >70 years-old (OR = 16.9, 95% CI 7.1-39.9), and blood group A (OR = 1.9, 95% CI: 1.1-3.4) with higher mortality risk. The strong association between mortality and relatively young age, may be due to high frequency of undiagnosed comorbidities. Vaccination was associated with a reduction in mortality only when time period of hospitalization was not adjusted for. CONCLUSION: Among hospitalized patients in Bolivia male sex, older age, and blood group A are associated with higher mortality risk. Mortality risk increased markedly from a relatively young age and decreased in parallel to the uptake of the vaccination program. However, the gradual reduction in mortality can also be due to improved patient management and changes in natural immunity and virulence of circulating strains as the pandemic progressed.
format Online
Article
Text
id pubmed-10643226
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106432262023-11-01 Risk factors for COVID-19 mortality in hospitalized patients in Bolivia Limachi-Choque, Jhonny Guitian, Javier Leyns, Christine Guzman-Rivero, Miguel Eid, Daniel IJID Reg Original Report OBJECTIVES: This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. METHODS: This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infection in a Bolivian hospital between April 6, 2020, and August 18, 2022. RESULTS: The results provide evidence of association between male sex (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.06-2.6), older age, 51-61 years-old (OR = 5.2, 95% CI 2.2-12.6), 62-70 years-old (OR = 8.7, 95% CI 3.7-20.5), >70 years-old (OR = 16.9, 95% CI 7.1-39.9), and blood group A (OR = 1.9, 95% CI: 1.1-3.4) with higher mortality risk. The strong association between mortality and relatively young age, may be due to high frequency of undiagnosed comorbidities. Vaccination was associated with a reduction in mortality only when time period of hospitalization was not adjusted for. CONCLUSION: Among hospitalized patients in Bolivia male sex, older age, and blood group A are associated with higher mortality risk. Mortality risk increased markedly from a relatively young age and decreased in parallel to the uptake of the vaccination program. However, the gradual reduction in mortality can also be due to improved patient management and changes in natural immunity and virulence of circulating strains as the pandemic progressed. Elsevier 2023-11-01 /pmc/articles/PMC10643226/ /pubmed/38020182 http://dx.doi.org/10.1016/j.ijregi.2023.10.002 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Report
Limachi-Choque, Jhonny
Guitian, Javier
Leyns, Christine
Guzman-Rivero, Miguel
Eid, Daniel
Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
title Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
title_full Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
title_fullStr Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
title_full_unstemmed Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
title_short Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
title_sort risk factors for covid-19 mortality in hospitalized patients in bolivia
topic Original Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643226/
https://www.ncbi.nlm.nih.gov/pubmed/38020182
http://dx.doi.org/10.1016/j.ijregi.2023.10.002
work_keys_str_mv AT limachichoquejhonny riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia
AT guitianjavier riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia
AT leynschristine riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia
AT guzmanriveromiguel riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia
AT eiddaniel riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia